Clinical Trials in Glasgow - 27 Recruiting Industry Studies

Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer · started 2022-10-14

📍 London · Liverpool · Glasgow · Redhill · Aberdeen

NCT05587296 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

Dravet Syndrome
Encoded Therapeutics · started 2024-05-14

📍 Glasgow · London

NCT05419492 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia (ITP), ITP - Immune Thrombocytopenia, ITP, Immune Thrombocytopenic Purpura
argenx · started 2025-10-20

📍 Cardiff · Glasgow · Manchester

NCT07194850 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Type 1 Diabetes Mellitus
Sanofi · started 2025-08-06

📍 Cambridge · Dundee · London · Glasgow · Bath

NCT07088068 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics · started 2025-01-28

📍 Aberdeen · Birmingham · Cambridge · Glasgow · Leeds

NCT06788990 on ClinicalTrials.gov ↗

Active Phase 3

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
Pfizer · started 2014-12-17

📍 Glasgow · Wonford · London · Sutton · Birmingham

NCT02319837 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC · started 2021-05-12

📍 Cambridge · Glasgow · London · Newcastle upon Tyne · Sheffield

NCT07218029 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Menstrual Migraine
Pfizer · started 2025-03-11

📍 Bristol · Milton Keynes · Hull · London · Fazakerley

NCT06641466 on ClinicalTrials.gov ↗

Recruiting Phase 3

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim · started 2024-11-07

📍 Aberdeen · Bristol · Camberley · Derby · Edgbaston, Birmingham

NCT06632457 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Metastatic Castration-Resistant Prostate Cancer
Pfizer · started 2024-10-22

📍 Blackburn · Chelmsford · Derby · Glasgow · Metropolitan Borough of Wirral

NCT06629779 on ClinicalTrials.gov ↗

Recruiting

Registry for Patients With X-Linked Hypophosphatemia

X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd · started 2017-09-12

📍 Belfast · Birmingham · Bristol · Cambridge · Cardiff

NCT03193476 on ClinicalTrials.gov ↗

Active Phase 3

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

Follicular Lymphoma (FL)
Genmab · started 2022-09-20

📍 Plymouth · Glasgow · London · Oxford · Leeds

NCT05409066 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

Lichen Planopilaris
Priovant Therapeutics, Inc. · started 2026-03-19

📍 Salford · Glasgow · Brighton · London · Wrexham

NCT07532603 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. · started 2024-03-13

📍 High Wycombe · Bristol · Glasgow · Hull · London

NCT06318169 on ClinicalTrials.gov ↗

Recruiting Phase 1

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer, HGSOC, HGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Epitopea Ltd · started 2026-07

📍 Cambridge · Edinburgh · Glasgow · Leeds · Leicester

NCT07665515 on ClinicalTrials.gov ↗

Recruiting Phase 3

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors, Hematologic Malignancies
Merck Sharp & Dohme LLC · started 2018-08-21

📍 Aberdeen · Cambridge · Edinburgh · Manchester · Sheffield

NCT03486873 on ClinicalTrials.gov ↗

No trials match your search.

Browse by city

London · 118 Manchester · 30 Glasgow · 27 Cambridge · 27 Birmingham · 24 Leicester · 23 Bristol · 23 Leeds · 22 Sutton · 19 Oxford · 19 Liverpool · 18 Edinburgh · 15 Nottingham · 14 Cardiff · 14 Newcastle upon Tyne · 13 Sheffield · 12

Browse by condition

Obesity · 5 Chronic Lymphocytic Leukemia · 5 Cancer · 4 Breast Neoplasms · 3 Non-small Cell Lung Cancer · 3 Small Lymphocytic Lymphoma · 3 Multiple Myeloma · 3 Hypertension · 3 Heart Failure · 3 Triple Negative Breast Neoplasms · 2 Lymphoma, Non-Hodgkin · 2 Lymphoma, Follicular · 2 Lymphoma, Large B-Cell, Diffuse · 2 Gastric Cancer · 2 Metastatic Prostate Cancer · 2 Overweight · 2

Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/glasgow (Accessed: 11 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.